I.v. selexipag ( DrugBank: Selexipag )

1 disease

ID	Disease name (Link within this page)	Number of trials
86	Pulmonary arterial hypertension	1

86. Pulmonary arterial hypertension

Clinical trials : 1,181 / Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03187678 (ClinicalTrials.gov)	December 4, 2017	9/6/2017	Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulm ...	A Multicenter, Open-label, Single-sequence Cross-over Study to Assess Safety, Tolerability, and Phar ...	Pulmonary Arterial Hypertension	Drug: i.v. selexipag;Drug: oral selexipag (Uptravi)	Actelion	NULL	Completed	18 Years	75 Years	All	20	Phase 3	United States;Germany

First Previous1Next Last